HIGHLIGHTS
- who: Yeeun Kim and colleagues from the Department of Radiation Oncology, Samsung Medical Center, Seoul, Republic of Korea Department of Radiation Oncology, Sungkyunkwan University School of Medicine have published the article: Immunomodulation of HDAC Inhibitor Entinostat Potentiates the Anticancer Effects of Radiation and PD-1 Blockade in the Murine Lewis Lung Carcinoma Model, in the Journal: (JOURNAL) of 18/Oct/2019
- what: The authors showed that the histone deacetylase inhibitor entinostat potentiated the efficacy of radiotherapy and anti-PD-1 using a murine syngeneic LL/2 tumor model.
- how: The authors investigated whether . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.